Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

P3 Health Partners (PIII) Common Equity: 2019-2024

Historic Common Equity for P3 Health Partners (PIII) over the last 6 years, with FY2024 value amounting to $75.9 million.

  • P3 Health Partners' Common Equity fell 11550.53% to -$18.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$18.7 million, marking a year-over-year decrease of 11550.53%. This contributed to the annual value of $75.9 million for FY2024, which is 4657.29% down from last year.
  • According to the latest figures from FY2024, P3 Health Partners' Common Equity is $75.9 million, which was down 4657.29% from $142.1 million recorded in FY2023.
  • In the past 5 years, P3 Health Partners' Common Equity ranged from a high of $142.1 million in FY2023 and a low of -$272.9 million during FY2021
  • In the last 5 years, P3 Health Partners' Common Equity had a median value of $5.9 million in 2022 and averaged -$35.8 million.
  • As far as peak fluctuations go, P3 Health Partners' Common Equity skyrocketed by 232791.25% in 2023, and later crashed by 4657.29% in 2024.
  • Over the past 5 years, P3 Health Partners' Common Equity (Annual) stood at -$130.2 million in 2020, then crashed by 109.59% to -$272.9 million in 2021, then skyrocketed by 102.14% to $5.9 million in 2022, then soared by 2327.91% to $142.1 million in 2023, then crashed by 46.57% to $75.9 million in 2024.
  • Its Common Equity was $75.9 million in FY2024, compared to $142.1 million in FY2023 and $5.9 million in FY2022.